Indonesia
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 302.38 M
|
Dec. 31, 2023 | USD 0.07 | -5.68% |
|
Indonesia |
|
2 |
USD 12.26 M
|
Dec. 31, 2023 | USD 0.01 | -3.10% |
|
Indonesia |
|
3 |
USD 7.18 M
|
Dec. 31, 2023 | USD 0.02 | -2.87% |
|
Indonesia |
|
4 |
USD 6.58 M
|
Dec. 31, 2023 | USD 0.21 | -0.01% |
|
Indonesia |
|
5 |
USD 2.49 M
|
Dec. 31, 2023 | USD 0.01 | -3.26% |
|
Indonesia |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 0.04 | -2.78% |
|
Indonesia |
The Biotechnology company in Indonesia with the highest Receivables is PT Kalbe Farma Tbk. (Jakarta Stock Exchange: KLBF.JK) at USD 302.38 M.
The Biotechnology company in Indonesia with the lowest Receivables is PT Soho Global Health Tbk (Jakarta Stock Exchange: SOHO.JK) at USD 0.00.
The top 10 Biotechnology companies in Indonesia by Receivables are PT Kalbe Farma Tbk., PT Pyridam Farma Tbk, PT Bundamedik Tbk, PT Merck Tbk, PT Diagnos Laboratorium Utama Tbk and PT Soho Global Health Tbk.
The bottom 10 Biotechnology companies in Indonesia by Receivables are PT Soho Global Health Tbk, PT Diagnos Laboratorium Utama Tbk, PT Merck Tbk, PT Bundamedik Tbk, PT Pyridam Farma Tbk and PT Kalbe Farma Tbk..